A Phase Ib/II Clinical Trial of M701 in the Treatment of Malignant Pleural Effusions Caused by NSCLC
Clinical trial NCT05543330 · RECRUITING
Trial details
- NCT number
- NCT05543330
- Sponsor
- Wuhan YZY Biopharma Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-30
- Primary completion
- 2026-09-15
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.